Veer Global Inf. (543241)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive book value of ₹21.43 per share provides a stated asset base.
• ROCE of 9.20% is positive, suggesting some operating-level capital efficiency.
• Listed in residential and commercial real estate, giving long-term optionality if execution improves.
• Price near its 52-week high shows strong market interest, though not a value signal.

Concerns

• ROE is negative at -2.21%, and the latest quarter shows net profit of ₹0 Cr.
• Sales declined 14.58% and profits declined 36.54%, indicating deteriorating fundamentals.
• Valuation is expensive at P/E of 84.93 and P/B of 8.45 versus book value of ₹21.43.
• Piotroski F-Score of 3/9 and undisclosed promoter holding raise governance and financial-health red flags.

AI Analysis

At ₹181, Veer Global Inf. has the look of a market favorite, not a business that I can understand or underwrite. My first test is return on equity: the company reports ROE of -2.21%. That means shareholders' equity is not earning its keep. Book value is just ₹21.43 per share, yet the market demands ₹181, or 8.45 times book. For any capital allocator, paying that multiple for negative ROE and a declining top line is the opposite of a margin of safety. Sales are down 14.58% and profits are down 36.54%. The latest quarter tells the story: sales of ₹2 Cr and net profit of ₹0 Cr. Against a ₹298 Cr market cap, this is not an operating business; it is a hope priced as a compounder. A P/E of 84.93 would need flawless execution and decades of growth to justify. A Piotroski F-score of 3 out of 9 suggests poor financial health, and a zero dividend yield means the investor receives no compensation for waiting. Promoter holding is not disclosed, which only adds to the governance fog. ROCE of 9.20% is the one positive figure, but with negative ROE and such tiny scale, it does not indicate a durable moat. Residential and commercial real estate in India can be cyclical; this stock appears to be riding that cyclical optimism, with the price at the high end of its 52-week range of ₹71.81 to ₹181.00. At this price, the future growth is already priced in, and the numbers do not support it. This is not a wonderful business at a fair price. It is a weak business at a rich price. I will not invest in what I cannot value, and I cannot value a company where the fundamentals point one way and the price the other. I would wait on the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer